Centre Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Centre Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-196,298	Closed	-$10.2M	–	57
2024 Q3	$10.2M	Buy	+196,298	New	+$9.21M	2.19%	24
2019 Q1	–	Sell	-175,670	Closed	-$9.13M	–	65
2018 Q4	$9.13M	Buy	+175,670	New	+$9.44M	2.69%	9
2016 Q3	–	Sell	-10,200	Closed	-$750K	–	66
2016 Q2	$750K	Hold	10,200	–	–	0.13%	58
2016 Q1	$652K	Sell	10,200 -3,070	-23%	-$194K	0.11%	63
2015 Q4	$913K	Hold	13,270	–	–	0.16%	58
2015 Q3	$786K	Hold	13,270	–	–	0.14%	59
2015 Q2	$883K	Sell	13,270 -3,630	-21%	-$239K	0.14%	68
2015 Q1	$1.09M	Hold	16,900	–	–	0.16%	61
2014 Q4	$998K	Hold	16,900	–	–	0.15%	67
2014 Q3	$865K	Buy	+16,900	New	+$844K	0.13%	79

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Centre Asset Management's BMY Position: Q4 2024 in Review

Centre Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2024, closing a stake of 196,298 shares — an estimated $10.2M sold.

Centre Asset Management first reported a position in BMY in Q3 2014 and held it in 10 quarters. The position peaked at $10.2M in Q3 2024. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

Centre Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2024 after selling out during the quarter.
Centre Asset Management sold 196,298 Bristol-Myers Squibb shares in Q4 2024, an estimated $10.2M.
Centre Asset Management first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 10 quarters.
Centre Asset Management's Bristol-Myers Squibb position peaked at $10.2M in Q3 2024.
2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Centre Asset Management's 13F filing for Q4 2024, filed 3 Jan 2025.